AMAM
Ambrx Biopharma Inc
AMAM
AMAM
Delisted
AMAM was delisted on the 6th of March, 2024.
16 hedge funds and large institutions have $152M invested in Ambrx Biopharma Inc in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$18.5M | |
| 2 | +$11.8M | |
| 3 | +$9.55M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$871K |
| 5 |
Renaissance Technologies
New York
|
+$107K |
Top Sellers
| 1 | -$389K | |
| 2 | -$243K | |
| 3 | -$203K | |
| 4 |
OCA
Octagon Capital Advisors
New York
|
-$119K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.8K |